» Articles » PMID: 17109858

Association of Anti-mullerian Hormone Levels with Obesity in Late Reproductive-age Women

Overview
Journal Fertil Steril
Date 2006 Nov 18
PMID 17109858
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe anti-mullerian hormone (AMH) levels in healthy late reproductive age women and test the hypothesis that AMH levels are lower in obese compared to non-obese women.

Design: Cross-sectional study of AMH levels. Longitudinal analysis of a subgroup with 10 AMH measures over 8 years to support the cross-sectional results.

Setting: A population-based cohort of healthy late reproductive-age women.

Participants: Selected from the cohort to provide comparisons of body mass index (BMI), menopausal status, age and race (n = 122).

Interventions: AMH levels were determined from blood samples collected in the parent study.

Main Outcome Measure: Serum levels of AMH.

Results: AMH levels were 65% lower in obese women compared to non-obese women (0.016 ng/mL and 0.046 ng/mL, respectively). The geometric mean ratio was 0.35; 95% CI 0.13, 0.92, P=.034. AMH levels were significantly lower in the menopausal transition compared to premenopausal women and were significantly lower in all age groups > or =40 years compared to the 35-39 year-old women. BMI remained significantly associated with AMH levels in multivariable models that included adjustments for menopausal status, age, race and cycle day. In the longitudinal analysis of a subgroup, obese women had significantly lower mean AMH levels over the 8-year interval compared to the non-obese women (0.459 ng/mL; CI 0.28, 0.75 and 0.566 ng/mL; CI 0.34, 0.94, respectively; P=.016), corroborating the cross-sectional study results.

Conclusions: Obese women have lower AMH levels compared to non-obese women in the late reproductive years. The findings offer further evidence of the complex relationships between obesity and reproductive hormone levels in women.

Citing Articles

A Novel method for quantifying fluctuations in wearable derived daily cardiovascular parameters across the menstrual cycle.

Jasinski S, Presby D, Grosicki G, Capodilupo E, Lee V NPJ Digit Med. 2024; 7(1):373.

PMID: 39715818 PMC: 11666598. DOI: 10.1038/s41746-024-01394-0.


Impact of psychological stress on ovarian function: Insights, mechanisms and intervention strategies (Review).

Hu Y, Wang W, Ma W, Wang W, Ren W, Wang S Int J Mol Med. 2024; 55(2).

PMID: 39704226 PMC: 11670866. DOI: 10.3892/ijmm.2024.5475.


Estimation of fatty acid composition in mammary adipose tissue using deep neural network with unsupervised training.

Chaudhary S, Lane E, Levy A, McGrath A, Mema E, Reichmann M Magn Reson Med. 2024; 93(5):2163-2175.

PMID: 39641987 PMC: 11893257. DOI: 10.1002/mrm.30401.


High-fat diet-induced L-saccharopine accumulation inhibits estradiol synthesis and damages oocyte quality by disturbing mitochondrial homeostasis.

Wen J, Feng Y, Xue L, Yuan S, Chen Q, Luo A Gut Microbes. 2024; 16(1):2412381.

PMID: 39410876 PMC: 11485700. DOI: 10.1080/19490976.2024.2412381.


Effect of body mass index on ovarian reserve and ART outcomes in infertile women: a large retrospective study.

Li Y, Yan E, Zhao G, Jin L, Ma B J Ovarian Res. 2024; 17(1):195.

PMID: 39358769 PMC: 11447952. DOI: 10.1186/s13048-024-01521-1.